Miconazole – 30 μg Antibiotic Disc – Bioanalyse

Miconazole – 30 μg Antibiotic Disc – Bioanalyse Overview

The Miconazole – 30 μg Antibiotic Disc – Bioanalyse is a precisely manufactured, high-quality diagnostic tool essential for antimicrobial susceptibility testing (AST). Utilizing the standard disc diffusion method, this product empowers clinical laboratories and healthcare professionals in Bangladesh to accurately determine the susceptibility of various fungi to miconazole, a potent broad-spectrum antifungal agent. This aids in the effective diagnosis and targeted treatment of a wide array of fungal infections, from common yeast infections to more persistent dermatophyte and mold-related conditions. Trust Bioanalyse for reliable results that inform critical patient care decisions.

Miconazole – 30 μg Antibiotic Disc – Bioanalyse Key Features

• Accurate Susceptibility Testing: Impregnated with a precise 30 μg concentration of Miconazole, ensuring reliable and reproducible results in antifungal susceptibility testing.
• Broad-Spectrum Efficacy: Miconazole is proven effective against a wide range of fungal pathogens, including yeasts, molds, and dermatophytes, making these discs versatile for diverse diagnostic needs.
• User-Friendly Application: Designed for straightforward use with the disc diffusion method, simplifying the workflow for laboratory technicians and clinicians.
• Quality Assured: Manufactured by Bioanalyse, a reputable name synonymous with high-quality diagnostic reagents and laboratory supplies, guaranteeing consistent performance.
• Informs Treatment Decisions: Provides crucial data to guide the selection of appropriate antifungal therapies for conditions such as vaginal candidiasis, oral thrush, athlete’s foot, ringworm, and nail fungus.

Technical Specifications

• Product: Miconazole Antibiotic Disc
• Concentration: 30 μg per disc
• Antifungal Agent: Miconazole
• Method Compatibility: Disc Diffusion Method for Fungal Susceptibility Testing
• Manufacturer: Bioanalyse
• Application: In vitro diagnostic use for determining fungal susceptibility to Miconazole.
• Interpretation Guidelines: Standardized zones of inhibition for Susceptible (≥ 26 mm), Intermediate (16-25 mm), and Resistant (< 16 mm) are provided to aid in result interpretation.

Understanding Test Results and Limitations

The Miconazole – 30 μg Antibiotic Disc – Bioanalyse facilitates the interpretation of fungal susceptibility through zone of inhibition measurements. A zone diameter of ≥ 26 mm indicates susceptibility, while a range of 16-25 mm suggests intermediate susceptibility. Zones < 16 mm typically denote resistance. It is crucial to recognize that the disc diffusion method offers semi-quantitative results. For definitive and more precise susceptibility data, advanced methods like broth microdilution or agar dilution are recommended. Furthermore, while highly effective, this method may not detect all resistant fungal strains, and results can be influenced by standardized laboratory conditions, including agar type, incubation temperature, and inoculum density. Always adhere to established protocols for optimal accuracy.

Important Considerations and Safety

Miconazole is generally well-tolerated and effective. However, as with any antifungal agent, potential side effects such as burning, itching, redness, or swelling may occur. Serious allergic reactions are rare but possible. Patients with known allergies to miconazole or other azole antifungals should not use this product. Consult with a healthcare professional for personalized medical advice and before initiating any treatment regimen based on these test results. For the most reliable diagnostic tools in Bangladesh, choose Medivillabd.